ET
BNTX icon

Entropy Technologies’s BioNTech BNTX Stock Holding History

Entropy Technologies’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$488K Buy
+5,241
New +$493K 0.02% 670

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Entropy Technologies's BNTX Position: Q2 2026 in Review

Entropy Technologies opened a new position in BioNTech (BNTX) in Q2 2026: 5,241 shares worth $488K. The stake represents 0.02% of the portfolio and ranks #670 among its holdings.

281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Entropy Technologies held 5,241 shares of BioNTech worth $488K as of Q2 2026.
  • BioNTech was a new Entropy Technologies position in Q2 2026.
  • BioNTech made up 0.02% of Entropy Technologies's portfolio in Q2 2026, its #670 holding.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.